Telehealth Pulmonary Rehabilitation for COPD
Trial Summary
What is the purpose of this trial?
The purpose of this study is to compare the efficacy and safety of a real time video telehealth pulmonary rehabilitation intervention with standard of care in patients hospitalized for an exacerbation of chronic obstructive pulmonary disease (COPD) to determine the impact on hospital readmissions and respiratory morbidity, and to investigate the cost-effectiveness of the intervention.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Video Telehealth Pulmonary Rehabilitation, Telehealth Pulmonary Rehabilitation, Virtual Pulmonary Rehabilitation, Telerehabilitation for COPD?
Is telehealth pulmonary rehabilitation safe for people with COPD?
How is the treatment 'Video Telehealth Pulmonary Rehabilitation' different from other treatments for COPD?
Video Telehealth Pulmonary Rehabilitation is unique because it allows COPD patients to participate in rehabilitation programs from home using video technology, making it more accessible and convenient compared to traditional in-person rehabilitation sessions. This approach can enhance patient participation and provide clinical and social benefits, especially for those who have limited access to conventional rehabilitation centers.12345
Research Team
Surya Bhatt, MD
Principal Investigator
University of Alabama at Birmingham
Eligibility Criteria
This trial is for adults aged 40-85 hospitalized with a flare-up of COPD, willing to follow the study plan and give consent. Excluded are those with terminal illnesses, severe heart failure, cognitive issues preventing safe participation, non-English speakers, certain immunosuppressed states or active cancers, recent heart attacks or on invasive ventilation.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive video telehealth pulmonary rehabilitation sessions three times a week for 12 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 13 weeks and 52 weeks
Treatment Details
Interventions
- Video Telehealth Pulmonary Rehabilitation (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor
Kierstin Kennedy
University of Alabama at Birmingham
Chief Medical Officer since 2022
MD
S. Dawn Bulgarella
University of Alabama at Birmingham
Chief Executive Officer since 2023
BSc in Commerce and Business Administration from the University of Alabama, MS in Health Administration from the University of Alabama at Birmingham
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
Dr. Gary H. Gibbons
National Heart, Lung, and Blood Institute (NHLBI)
Chief Executive Officer since 2012
MD from Harvard Medical School
Dr. James P. Kiley
National Heart, Lung, and Blood Institute (NHLBI)
Chief Medical Officer since 2011
MD from University of California, San Francisco